Pacific Biosciences Of California (PACB) Assets Average (2010 - 2026)

Pacific Biosciences Of California has reported Assets Average for 17 years, with the latest figure at $767.1 million in Q2 2026.

• On a quarterly basis, Assets Average fell 9.02% year-over-year to $767.1 million in Q2 2026; TTM through Jun 2026 was $767.1 million, a 9.02% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, down 32.0% from the prior year.
• Assets Average was $767.1 million for Q2 2026 at Pacific Biosciences Of California, down from $783.2 million in the prior quarter.
• The five-year high for Assets Average was $2.0 billion in Q1 2022, with the low at $767.1 million in Q2 2026.
• Average Assets Average over 5 years is $1.5 billion, with a median of $1.6 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Assets Average jumped 195.85% in 2022, then plunged 46.96% in 2025.
• Over 5 years, Assets Average stood at $1.8 billion in 2022, then rose by 1.63% to $1.8 billion in 2023, then decreased by 25.62% to $1.4 billion in 2024, then slumped by 41.44% to $793.6 million in 2025, then dropped by 3.34% to $767.1 million in 2026.
• The last three Assets Average figures came in at $767.1 million (Q2 2026), $783.2 million (Q1 2026), and $793.6 million (Q4 2025), per Business Quant data.